Fidelity Investments’s Chembio diagnostics, Inc. CEMI Stock Holding History

Fidelity Investments’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-339	Closed	–	–	5759
2021 Q4	$0	Buy	339 +210	+163%	+$428	﹤0.01%	5254
2021 Q3	$0	Buy	129 +128	+12,800%	+$355	﹤0.01%	5397
2021 Q2	$0	Buy	+1	New	+$3	﹤0.01%	5240

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments's CEMI Position: Q1 2022 in Review

Fidelity Investments sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2022, closing a stake of 339 shares.

Fidelity Investments first reported a position in CEMI in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q4 2021. 36 funds tracked by Wall St. Rank hold CEMI as of Q1 2022.

Fidelity Investments reported no remaining Chembio diagnostics, Inc. position as of Q1 2022 after selling out during the quarter.
Fidelity Investments sold 339 Chembio diagnostics, Inc. shares in Q1 2022.
Fidelity Investments first reported a position in Chembio diagnostics, Inc. in Q2 2021 and held it in 3 quarters.
Fidelity Investments's Chembio diagnostics, Inc. position peaked at $0 in Q4 2021.
36 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2022.

Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.